Interference No. 103,605
FINAL DECISION UNDER 37 CFR § 1.658
This interference involves an application of the junior
party, Aggarwal, and a patent of the senior party, Yamada et al.
(Yamada)3.
According to the record before us, the involved Aggarwal
application is assigned to Genentech, Inc.; and the involved
Yamada patent is assigned to Dainippon Pharmaceutical Co., Ltd.
The subject matter involved in this interference relates to
a polypeptide having human tumor necrosis factor activity, and
which is more particularly defined by the following count, the
only count in this interference:
Count 1
1. A polypeptide having human tumor necrosis factor
activity and being selected from the group consisting of
(a) the polypeptide having the amino acid sequence of the
following formula, and
(b) a polypeptide having an amino acid sequence resulting
from the addition of one or two amino acid residues from the
precursor portion of said polypeptide (a) to the N-terminus of
the following formula:
3 We note that Yamada was accorded senior party status in the
Decision on Motions (Paper No. 43, page 6) of Oct. 21, 1998.
2
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007